MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PD-1/PD-L1-IN-NP19

CAS No. : 2377916-66-8

MCE 站：PD-1/PD-L1-IN-NP19

产品活性：PD-1/PD-L1-IN-NP19 是 PD-1/PD-L1 的抑制剂，抑制人类 PD-1/PD-L1 相互作用的 IC₅₀ 值为 12.5 nM。PD-1/PD-L1-IN-NP19 可以激活肿瘤的免疫微环境，这可能有助于其抗肿瘤作用。

研究领域：Immunology/Inflammation

作用靶点：PD-1/PD-L1

In Vitro: PD-1/PD-L1-IN-NP19 (compound NP19) (0.37-10 μM; 72 h) significantly elevates the production of IFN-γ in a dose dependent manner from T cells co-cultured with tumor cells.
PD-1/PD-L1-IN-NP19 exhibits much lower activity for inhibiting mouse PD-1/PD-L1 interaction with an IC₅₀ in the micromolar range (>1?M), as compared to the inhibition of human PD1/PD-L1 interaction (IC₅₀=12.5 nM).
PD-1/PD-L1-IN-NP19 (10 ?M; 48 h) displays no apparent cytotoxic effects on A549, MCF-7, and B16-F10 cells at a concentration of 10 ?M.

In Vivo: PD-1/PD-L1-IN-NP19 (compound NP19) (25-100 mg/kg; intragastric gavage once daily for 15 d) inhibits the growth of melanoma tumors dramatically in mice.
PD-1/PD-L1-IN-NP19 (25 mg/kg; i.p. daily for 14 d) demonstrates significant antitumor efficacy with a tumor growth inhibition (TGI) of 76.5% and is well tolerated in an H22 hepatoma mouse model.
PD-1/PD-L1-IN-NP19 (1 mg/kg; i.v.) shows the half time (t_1/2=1.5±0.5 h), clearance rate (CL=0.9±0.2 L/h/kg) and apparent distribution volume (Vss=2.1±0.5 L/kg) in rats.
PD-1/PD-L1-IN-NP19 (10 mg/kg; p.o.) shows the oral absorption (T_max=0.6±0.2 h), long half-life (t_1/2=10.9±7.7 h) and oral bioavailability (F=5%) in rats.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Anti-Cancer Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  BMS-1  |  Fraxinellone  |  BMS-1001 hydrochloride  |  Sulfamethoxypyridazine  |  TPP-1  |  Human PD-L1 inhibitor II  |  Human PD-L1 inhibitor III  |  Human PD-L1 inhibitor IV  |  Human PD-L1 inhibitor V

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。